1. Home
  2. CRC vs LGND Comparison

CRC vs LGND Comparison

Compare CRC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$60.16

Market Cap

4.7B

Sector

Energy

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$204.17

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
LGND
Founded
2014
1987
Country
United States
United States
Employees
N/A
68
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRC
LGND
Price
$60.16
$204.17
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$61.88
$245.17
AVG Volume (30 Days)
650.5K
144.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.08
Revenue Next Year
$3.53
$17.83
P/E Ratio
$13.50
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$33.69
$93.58
52 Week High
$62.48
$212.49

Technical Indicators

Market Signals
Indicator
CRC
LGND
Relative Strength Index (RSI) 64.97 64.18
Support Level $45.54 $198.52
Resistance Level N/A $207.72
Average True Range (ATR) 2.09 7.80
MACD 0.00 2.19
Stochastic Oscillator 70.41 93.00

Price Performance

Historical Comparison
CRC
LGND

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: